Dipeptidyl Peptidase (DPP)-4 Inhibitor Impairs the Outcomes of Patients with Type 2 Diabetes Mellitus After Curative Resection for Colorectal Cancer

Dipeptidyl peptidase IV inhibitor (DPP-4i) has been shown to act either as a promoter or as a suppressor for cancer. Although epidemiologic studies suggest that DPP-4i does not correlate with the development of malignancies, its effects on cancer metastases are controversial. We evaluated the impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Akira, Kitayama, Joji, Horie, Hisanaga, Koinuma, Koji, Kawashima, Rie, Ohzawa, Hideyuki, Yamaguchi, Hironori, Kawahira, Hiroshi, Mimura, Toshiki, Lefor, Alan Kawarai, Sata, Naohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973397/
https://www.ncbi.nlm.nih.gov/pubmed/36860286
http://dx.doi.org/10.1158/2767-9764.CRC-21-0042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973397/
https://www.ncbi.nlm.nih.gov/pubmed/36860286
http://dx.doi.org/10.1158/2767-9764.CRC-21-0042

Ejemplares similares